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Surveillance for inﬂ   uenza virus in pigs in the 
United Kingdom during spring 2010 detected a novel 
reassortant inﬂ  uenza virus. This virus had genes encoding 
internal proteins from pandemic (H1N1) 2009 virus and 
hemagglutinin and neuraminidase genes from swine 
inﬂ  uenza virus (H1N2). Our results demonstrate processes 
contributing to inﬂ  uenza virus heterogeneity.
D
uring the 1918 inﬂ  uenza pandemic, the virus likely 
passed from humans to pigs (1). Descendants of this 
virus (classical swine inﬂ  uenza viruses), ﬁ  rst isolated in 
1930 (2), have continued to circulate in pigs (1). Other 
inﬂ  uenza viruses have caused either sporadic or enzootic 
infections.
Until 2009, the predominant inﬂ  uenza virus subtypes in 
pigs in Europe were avian-like (H1N1), human-like (H3N2) 
(representing virus transmissions from birds and humans, 
respectively), and H1N2 (3). Subtype H1N2 viruses, ﬁ  rst 
identiﬁ  ed in the United Kingdom in 1994 and subsequently 
detected throughout Europe, arose by reassortment between 
human subtype H1N1 (hemagglutinin [HA] gene), human-
like swine subtype H3N2 (neuraminidase [NA] gene), 
and avian-like swine subtype H1N1 viruses (internal gene 
segments; 4,5).
Classical swine inﬂ   uenza viruses (H1N1) were 
dominant in North America (6). However, during the 
1990s, infection of pigs with human subtype H3N2 virus 
resulted in viruses containing a triple-reassortant group of 
internal genes. These viruses contain genes derived from 
human, classical swine, and avian-origin viruses and can 
accept different HA and NA genes (6).
Pandemic (H1N1) 2009 virus is a reassortant virus 
with genes from recent North American triple reassortant 
(basic polymerase 2 [PB2], PB1, acidic polymerase, HA, 
nucleoprotein [NP], nonstructural gene) and European 
avian-like subtype H1N1 (NA, matrix [M]) viruses (7). 
Infections of domestic pigs with pandemic (H1N1) 2009 
virus have been detected worldwide. In January 2010, a 
reassortant virus that contained a pandemic (H1N1) 2009 
virus NA gene and an avian-like subtype H1N1 HA gene 
was detected in pigs in Hong Kong (8). This reassortant 
was efﬁ  ciently transmitted between pigs (8). We report 
detection and characterization of a novel swine reassortant 
virus in the United Kingdom that has genes encoding 
internal proteins from pandemic (H1N1) 2009 virus and 
HA and NA genes from a swine subtype H1N2 virus.
The Study
In mid-April 2010, inﬂ  uenza-like illness was reported 
in pigs in a North Yorkshire gilt (female pig intended for 
breeding that has not farrowed) grower unit of ≈1,200 
animals. Gilts were brought into the unit in batches of ≈100 
animals at ≈5 months of age. The ﬁ  rst batch of gilts arrived 
in mid-January 2010; previously, the unit did not contain 
animals for >4 months. Gilts were housed in stable groups 
of ≈20 in a naturally vented building with a straw yard and 
remained in the unit for ≈70 days. The nearest pig farm was 
≈3 miles away.
A persistent moist cough and signs typical of epizootic 
swine inﬂ  uenza were observed in 40%–50% of a batch of 
pigs 2 weeks after their arrival. Seven days after the onset 
of clinical signs, nasal swabs and serum samples were 
obtained from 6 pigs, and serum samples were obtained 
from 4 acutely affected pigs. Convalescent-phase serum 
samples were obtained from 9 pigs in the same batch 21 
days later. Clinical signs had subsided by early June 2010.
Total RNA was extracted from swab eluant and 
ampliﬁ  ed by using an M gene real-time reverse transcription 
PCR (RT-PCR) capable of detecting pandemic (H1N1) 
2009 virus (9); 4 of 6 swabs were positive. None of the 
samples were positive for pandemic (H1N1) 2009 virus 
with a modiﬁ  ed real-time RT-PCR speciﬁ  c for the HA gene 
(9). Only the sample positive by real-time RT-PCR with the 
lowest cycle threshold value yielded virus when inoculated 
into embryonated fowl eggs (10). Egg-grown virus was 
identiﬁ   ed as subtype H1N2 by using hemagglutinin 
inhibition (HI) and NA inhibition with standard methods 
(10) and designated A/swine/England/1382/10 (H1N2). 
The virus was reisolated from the original sample to 
exclude cross-contamination.
A/swine/England/1382/10 was characterized by using 
whole genome sequencing and phylogenetic analysis. Gene 
fragments were ampliﬁ  ed by using a 1-step real-time RT-
PCR (QIAGEN, Hilden, Germany), and HA and NA genes 
were sequenced by using subtype H1N2 virus–speciﬁ  c 
primers (5). Partial internal gene segment sequencing 
was initially performed by using primer pairs (5). Full 
sequencing of internal gene segments used universal (NP, 
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Analysis of sequence data by BLAST analysis (http://
blast.ncbi.nlm.nih.gov) determined the closest similarity to 
inﬂ  uenza virus isolates in the GenBank database. A/swine/
England/1382/10 had HA and NA genes closely related 
to UK swine subtype H1N2 viruses (Table 1). All genes 
encoding internal proteins showed the highest similarity to 
pandemic (H1N1) 2009 viruses (Table 1).
HA and NA genes of A/swine/England/1382/10 
grouped within the European swine subtype H1N2 cluster, 
speciﬁ   cally, with contemporary subtype H1N2 isolates 
from England. The closest matching isolate for HA and 
NA was A/swine/England/1428/09, which is reported in 
this article (Figure).
The M gene of A/swine/England/1382/10 had 
the S31N amantadine-resistance mutation, typical of 
pandemic (H1N1) 2009 viruses. It also had 627E and 
701D mutations in the PB2 gene and mutation 591R, a 
basic amino acid that reportedly compensates for lack 
of the 627K mammalian-adaptive mutation (14). The 
PB1-F2 open-reading frame encoded a truncated PB1-F2 
protein of 11 aa, consistent with other pandemic (H1N1) 
2009 viruses. The NA gene has mutations 119E and 292R, 
which are associated with susceptibility to oseltamivir in 
N2 subtypes.
Since the emergence of pandemic (H1N1) 2009 virus, 
5 other subtype H1N2 viruses have been detected in pigs in 
the United Kingdom. Partial sequencing of internal genes 
of these viruses showed they were not reassortants (Table 
1). Reassortment was not detected in a European avian-like 
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Table 1. Genotypes of influenza virus subtype H1N2 and H1N1 isolates from pigs, United Kingdom, 2009–2010* 
Virus Date of sampling Subtype 
Gene segment 
PB2 PB1 PA HA NP NA M NS
A/swine/England/236/09  2009 Sep 28  H1N2  A A A H A H A A
A/swine/England/1157/09  2009 Oct 5  H1N2  A A A H A ND  A A
A/swine/England/1428/09  2009 Dec 8  H1N2  A A A H A H A A
A/swine/England/523/10  2010 Jan 4  H1N2  A A AHAHAA
A/swine/England/1382/10†  2010 Apr 13  H1N2  P P P H P H P P
A/swine/England/1389/10  2010 Apr 15  H1N1  A A A A A A A A
A/swine/England/73690/10  2010 Jun 23  H1N1‡  P P P P P P P P
*PB, basic polymerase; PA, acidic polymerase; HA, hemagglutinin; NP, nucleoprotein, NA, neuraminidase; M, matrix; NS, nonstructural; A, genes with 
closest homology to European avian-like swine influenza viruses (H1N1); H, genes with closest homology to European swine influenza viruses (H1N2); 
ND, gene not sequenced but typed as N2 by using standard NA inhibition assay; P, genes with closest homology to pandemic (H1N1) 2009 virus. Closest 
matching homologous genes were determined by analyzing nucleotide sequences (minimum of 180 bases) against the National Center for Biotechnology 
Information  GenBank database (http://blast.ncbi.nlm.nih.gov). GenBank accession nos. JF290388–JF290395 and JF297995–JF298002. 
†A/swine/England/1382/10 reassortant virus.  
‡Pandemic (H1N1) 2009 virus. 
Figure. Phylogenetic analysis of 
inﬂ  uenza A virus hemagglutinin 
(A) and neuraminidase (B) 
genes. Trees were constructed 
by using the neighbor-joining 
method. Solid diamonds indicate 
A/swine/England/1382/10 
genes from virus isolated in 
this study, and open diamonds 
indicate genes from other 
viruses reported in this study. 
Percentage of replicate trees 
in which the associated 
taxa clustered together in 
the bootstrap test (1,000 
replicates) is shown next to the 
branches for values >70% (11). 
Evolutionary distances were 
computed by using the Tamura-
Nei method (12). Phylogenetic 
analyses were conducted by 
using MEGA4 (13). Scale bars 
indicate nucleotide substitutions 
per site.Reassortant Pandemic (H1N1) 2009 Virus in Pigs
swine subtype H1N1 virus isolated from another pig unit 
in the same region in April 2010, or in a pandemic (H1N1) 
2009 virus isolated from another pig unit in the same region 
in June 2010 (Table 1).
The 10 acute-phase and 9 convalescent-phase serum 
samples were subjected to standard HI tests (10) with 
antigens from A/swine/England/195852/92 (avian-like 
subtype H1N1), A/swine/England/1353/09 pandemic 
(H1N1) 2009 virus, A/swine/England/438207/94 (subtype 
H1N2), and homologous A/swine/England/1382/10 (Table 
2). Acute-phase serum samples were positive for antibodies 
against pandemic (H1N1) 2009 virus. Titers increased >10-
fold in convalescent-phase serum samples. Antibody titers 
to endemic and reassortant subtype H1N2 viruses were 
negligible in acute-phase serum samples but increased 
14-fold and 16-fold, respectively, in convalescent-phase 
serum samples.
Conclusions
We report detection of a novel reassortant virus 
between pandemic (H1N1) 2009 virus and a swine subtype 
H1N2 virus. In contrast to an earlier report of a reassortant 
virus that contained the NA gene of pandemic (H1N1) 
2009 virus (8), in this study all genes encoding internal 
proteins of A/swine/England/1382/10 virus are derived 
from pandemic (H1N1) 2009 virus.
The source of A/swine/England/1382/10 could not 
be established. Appearance of clinical signs 2 weeks after 
arrival in the unit suggests that pigs were not previously 
infected with either a precursor or reassortant virus. 
However, detection of antibodies against pandemic (H1N1) 
2009 virus in pigs coinciding with appearance of clinical 
signs suggests earlier subclinical infection with pandemic 
(H1N1) 2009 virus preceding co-circulation of subtype 
H1N2 or reassortant H1N2 viruses once pigs arrived at the 
unit. Earlier sampling of pigs in the unit may have detected 
subclinical precursor viruses.
We did not ﬁ  nd evidence of similar reassortants in the 
United Kingdom. Therefore, it is unclear whether A/swine/
England/1382/10 can be transmitted between pigs or has 
any selective advantage.
Our serologic results and those of others (15) indicate 
that antibodies against pandemic (H1N1) 2009 virus or 
subtype H1N2 virus produced during natural infection of 
pigs do not show cross-reactivity in HI tests. Therefore, 
pandemic (H1N1) virus and subtype H1N2 virus may 
continuously circulate  in pigs in Europe, providing 
additional opportunities for reassortment.
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Table 2. Serologic cross-reactivity titers of acute-phase and convalescent-phase swine serum samples against subtypes of swine 
influenza viruses, United Kingdom* 
Phase and 
pig no. 
Virus
A/Swine/England/438207/94,  
subtype H1N2 
A/Swine/England/195852/92, 
subtype H1N1 
A/swine/England/1353/09, 
pandemic (H1N1) 2009 
A/swine/England/1382/10, 
reassortant subtype H1N2
Acute phase 
1 <10 40 320 <10
2 <10 <10 160 <10
3 <10 <10 160 <10
4 <10 <10 320 <10
5 <10 <10 160 <10
6 <10 <10 320 <10
7 <10 <10 640 <10
8 <10 <10 320 <10
9 <10 <10 <10 <10
10 <10 <10 80 <10
Convalescent phase 
1 80 20 2,560 160
2 <10 <10 5,120 160
3 <10 <10 2,560 80
4 160 160 1,280 160
5 <10 <10 1,280 80
6 640 160 5,120 160
7 <10 <10 2,560 320
8 160 40 5,120 320
9 320 320 2,560 160
*Acute-phase serum samples were obtained from 10 pigs in the same batch during the time when clinical signs were apparent (|2 wk after arrival at the 
unit). Convalescent-phase serum samples were obtained from 9 pigs in the same batch 21 d later. Standard hemagglutinin inhibition assays were 
conducted with subtype H1N1, pandemic (H1N1) 2009, and subtype H1N2 virus antigens derived from UK swine isolates. Homologous 
A/swine/England/1382/10 antigen was also used. Rural Affairs, Animal Health, and the Veterinary Laboratories 
Agency Regional Laboratory for cooperation and support during 
these investigations.
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